TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.
Yanling RenJinghan WangHua ZhangChen MeiLi YeYingwan LuoXinping ZhouShuanghong ZhuLingxu JiangLu WangJie JinHongyan TongPublished in: Asia-Pacific journal of clinical oncology (2020)
CK and vCK overlap in most of the MDS patients with MK. TP53 mutations occur more frequently in MDS patients with vCK, and both TP53 mutations and vCK are adverse prognostic factors.